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Remodeling in peripheral vein graft revisions:
Serial study with three-dimensional ultrasound
imaging
Daniel F. Leotta, PhD, Jean F. Primozich, BS, Kirk W. Beach, PhD, MD, Robert O. Bergelin, MS,
R. Eugene Zierler, MD, and D. Eugene Strandness, Jr, MD, Seattle, Wash
Objective: Remodeling of vein grafts in the lower limb can lead to stenotic lesions that threaten long-term graft patency.
Progressive changes in vein graft geometry were measured at sites of repaired stenoses with three-dimensional (3D)
ultrasound imaging.
Methods: Ten vein graft revisions with patch angioplasty were followed up for 31 to 47 weeks. Four revisions were at valve
sites, and six were at sites of diffuse intimal hyperplasia. Sets of spatially registered two-dimensional (2D) cross-sectional
ultrasound images were assembled to create 3D computer models of each vein graft. Cross-sectional area measurements
in planes normal to the vessel center axis were calculated from the 3D surface reconstructions. Data sets from serial studies
were registered in a common coordinate system, and cross-sectional area measurements were compared at matched sites.
Results: Three of the four vein graft revisions at valve sites changed by less than 18%, and one decreased in cross-sectional
area by 61%. Five of the six revisions at sites of diffuse intimal hyperplasia demonstrated significant decreases in lumen
area ranging from 26% to 61%, and one revision exhibited no significant change in cross-sectional area. Reproducibility
of the cross-sectional area measurements derived from the 3D imaging technique was 6.9%.
Conclusions: Sequential area measurements from 3D ultrasound scans demonstrated different remodeling patterns and
rates of change among revision sites within the vein grafts. Lumen narrowing documented with 3D scanning was not
associated with consistent flow velocity changes on conventional duplex graft surveillance scans. (J Vasc Surg 2003;37:
798-807.)
Chronic arterial occlusive disease of the lower limbs
leads to claudication, ischemic rest pain, and tissue loss.
Diseased arteries are often successfully treated with vein
bypass grafting. However, stenotic lesions develop in ap-
proximately 15% to 40% of these grafts, 80% within the first
2 years after graft placement.1 The most common cause of
vein graft failure is myointimal hyperplasia. The biologic
characteristics of this lesion seem to be a combination of
smooth muscle activation, proliferation of smooth muscle,
and production of extracellular matrix.2 Changes in flow
rates and the associated shear and tensile stress result in
arterial wall remodeling.3
Restenosis associated with vessel remodeling can affect
any area of the cardiovascular system that has undergone
some type of injury, including surgery and angioplasty. In
some areas of the circulation where vein bypass grafts are
used, such as the coronary arteries, it is difficult to identify
or monitor changes in the grafts over time. The invasive
nature of arteriography and intravascular ultrasound scan-
ning limits the frequency of their use in follow-up studies.
In the lower extremity, however, the status of vein bypass
grafts can be assessed with ultrasonic duplex scanning from
the time of implantation. Graft patency can be assessed, and
in most instances lesions that may either compromise flow
or lead to graft thrombosis can be detected. These exami-
nations depend exclusively on identification of hemody-
namically significant areas of narrowing by studying the
flow velocity patterns throughout the length of the graft.
Duplex scanning has been successfully used in the clinical
setting to identify lesions that must be revised to preserve
graft function.4
In our laboratory, surveillance studies of restenosis
secondary to myointimal hyperplasia have involved the
carotid artery and peripherally placed saphenous vein
grafts.5-8 This experience clearly showed that progression
and regression is a characteristic of myointimal hyperplasia.
These lesions can develop rapidly and progress to high-
grade stenosis or regress to lesser narrowing. However,
nearly all of our information on these lesions in human
beings is related to hemodynamic changes rather than to
anatomic changes associated with the geometric effects of
the lesions and the vessel response to injury. Investigation
continues regarding the anatomic changes that occur as the
vein graft in the leg matures and as stenotic lesions devel-
op.9-11 For instance, it has not been established whether
the vein grafts adapt to the developing lesions with com-
pensatory dilation as occurs in native arteries in response to
development of areas of narrowing.12 This information
could help predict the influence of remodeling on the
geometry of the vein graft and its long-term patency.
While the resolution of two-dimensional (2D) ultra-
sonic B-mode scans has improved, it is still not possible
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with this method alone to accurately characterize myointi-
mal lesions in terms of their exact location within the graft
and their extent, both circumferentially and longitudinally.
Therefore we are exploring the clinical utility of serial
cross-sectional area measurements derived from three-di-
mensional (3D) ultrasound scanning of lower extremity
bypass grafts to quantify changes in vein graft architecture.
The current study focused on sites of vein graft revision
with patch angioplasty, which represent well-defined seg-
ments for which progressive changes in geometry can be
tracked over time. Our goal was to provide precise docu-
mentation of the anatomic changes in the vessel at these
sites.
METHODS
Scanning and reconstruction. 3D imaging was per-
formed with a standard ultrasound scanner (Sonos 5500;
Agilent, Andover, Mass) and a magnetic tracking system
(Flock of Birds, Ascension Technology, Burlington, Vt)
fitted to the scanner head to register 2D ultrasound images
in a 3D coordinate system.13,14 Custom software running
on a Unix work station (O2; SGI, Mountain View, Calif)
was used to simultaneously acquire the ultrasound images
and the associated location data. Examinations were per-
formed with the patient on a wooden bed to minimize
distortion of the magnetic fields generated by the 3D
tracking system.
An image was recorded before each study with the scan
head placed at a fiducial point, typically the proximal or
distal end of the surgical scar line.15 The location informa-
tion acquired at this site establishes a landmark in 3D space
that is used to register serial data sets. The graft is then
manually scanned in cross-section through a region identi-
fied with standard duplex scanning as an area of interest
(Fig 1, A and B). Acquisition of a single image was initiated
with a hand switch and gated to an echocardiographic
signal. Imaging was performed in the power Doppler
mode, with the gray-scale background included. The 2D
images were gathered at intervals of 1 to 2 mm; 30 to 60
images were acquired in each area of interest. A set of
images typically was acquired in 3 to 5 minutes.
Automatic color segmentation defines the boundary of
the lumen on each of the 2D cross-sectional power Doppler
views of the vessel (Fig 1, C). The segmentation is reviewed
and manually edited if necessary. Editing is only required in
regions of bruits or vessel branching, where adjacent color
regions on the image overlap and confound the segmenta-
tion. The contour points are transformed to locations in the
3D coordinate system of the magnetic transmitter with use
of the position and orientation information associated with
each image plane. The center axis, defined by the centroids
of the contours, is smoothed by a three-point running
average; the contours are then shifted to the smoothed
centroid locations. Custom computer software connects
the contour points to neighboring outlines to form a
surface representation of the vessel (Fig 1, D).
Patient studies. Ten graft revisions with patch angio-
plasty were followed up for as long as 1 year. The revisions
were divided into two groups: revision of focal stenosis due
to fibrotic valve leaflets, and revision of regions of diffuse
lumen narrowing attributed to intimal hyperplasia. All
grafts were placed for treatment of occlusive disease. Data
for each case are summarized in Table I. Fig 2 shows
representative 3D surface reconstructions of the patches
because of valve stenosis or diffuse intimal hyperplasia.
Table I includes a dilation ratio to characterize patch size
relative to the normal graft, defined as the ratio of the
maximum diameter in the revised segment to the adjacent
unrevised graft diameter. Patients were followed up every 1
to 2 months for the first 6 months after revision, then at
3-month intervals for up to 1 year after surgery. Patients
with notable changes in flow rate were followed up more
frequently. Sixty-eight patient scans were compiled for this
study. The imaging protocol was approved by the institu-
tional review board, and all subjects gave informed consent.
Fig 1. Three-dimensional reconstruction procedure. A, Vessel is manually scanned in cross-section with power
Doppler method. B, Stack of 2D images with corresponding location information is saved. C, Vessel lumen is
segmented on each image. D, Individual outlines are registered in 3D space and connected to form a surface.
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Cross-sectional area measurements were computed
from the surface reconstructions by resampling the surface
in planes perpendicular to the center axis of the vessel.13,14
This processing step prevents errors in cross-sectional area
measurement due to oblique imaging planes. The resam-
pling was performed at 1 mm intervals along the center axis
path length, and the area of each of the resampled contours
was calculated to generate a profile of cross-sectional area
along the segment of the graft.
The minimum, maximum, and mean cross-sectional
areas in the revised segment were computed for each
study. Absolute and percent changes in mean cross-
sectional area were computed relative to the first study
after the revision. The mean cross-sectional area is equiv-
alent to segment volume divided by segment length;
percent changes in mean cross-sectional area are there-
fore equivalent to percent changes in volume. The revi-
sion site was delineated by manually marking the start
and end points of the patch for the first study after the
revision, based on the dilated region observed in the
cross-sectional area profile. All subsequent studies were
spatially registered with this reference scan so that the
cross-sectional area comparisons were computed for the
same segment of the vessel. Registration was performed
by correlation of the cross-sectional area profiles after
initial registration based on the fiducial points. In cases
H2 and H6 focal stenoses developed that were greater
than 75% with duplex scanning flow velocity criteria16
Fig 2. Surface reconstructions of representative patch angioplasties. Top, Patch to repair valve stenosis (case V1, first
study) in mid-graft. Bottom, Patch to repair stenosis due to intimal hyperplasia (case H1, first study) at the proximal
anastomosis with the common femoral artery (CFA). Patched valve sites are generally smaller in both length and
diameter than patched intimal hyperplasia sites. Blood flow is from left to right.
Table I. Vein graft revision with patch angioplasty*
Case
Patient
(age/sex)
Graft
type
Graft age
at time of
revision (wk)
Unrevised
graft
diameter† (mm)
Patch
type
Patch
site
Patch
length
(mm)
Patch
dilation
ratio‡
First
study
(wk)
Last
study
(wk)
Valve stenosis
V1 52/M RSV 24 4.7 Vein Body 27 1.9 5 39
V2 85/M RSV 12 5.0 Vein Body 30 1.6 3 40
V3 54/F Transposed nonreversed 9 5.0 Vein Body 16 1.5 3 40
V4 52/M RSV 35 4.0 Vein Body 32 2.2 4 43
Diffuse intimal hyperplasia
H1 56/M RSV 54 5.4 Vein Proximal anastomosis 75 2.7 4 31
H2 35/M RSV 68 3.1 Vein Body 32 3.2 2 32
H3 72/F In situ 41 6.5 Vein Body 40 1.7 2 38
H4 71/M RSV 34 5.5 Vein Proximal anastomosis 35 2.6 5 40
H5 58/M Reversed cephalic vein 47 5.1 Dacron Proximal anastomosis 41 2.6 4 40
H6 74/F In situ 50 5.1 Vein Proximal anastomosis 38 2.2 3 47
RSV, Reversed saphenous vein.
*Study times are relative to time of revision. Cases in each group are listed in order of total follow-up time.
†Unrevised graft diameter: average for 1 to 2 cm segment adjacent to patch.
‡Patch dilation ratio: Maximum patch diameter/adjacent unrevised diameter.
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during the study period. The cross-sectional area at the
stenosis was measured at all time points for these two
cases.
Reproducibility. Reproducibility is the variability ob-
served in multiple measurements of the same quantity.
Repeated scans of the revision sites were performed at 27 of
the 68 patient visits, including 7 of the 10 patients. Mea-
surements from the repeated scans were compared to pro-
vide an estimate of variability of the 3D reconstructions.
The paired resampled data sets were registered in a com-
mon 3D coordinate system based on the fiducial points
acquired with each scan. The mean cross-sectional area of
the patched site was calculated for each data set, and the
difference between the means was calculated. This differ-
ence was divided by the mean of the two results to yield a
percentage disagreement. The mean and SD of the differ-
ences for all repeated studies were calculated.
RESULTS
The percent change in mean cross-sectional area from
the initial study is plotted over time in Fig 3 for each case.
The changes in cross-sectional area between the first and
last studies are summarized in Table II for all cases. A
detailed display for a representative case of vessel remodel-
ing (case H1) is shown in Fig 4. The 3D surface reconstruc-
tions and corresponding cross-sectional area measurements
demonstrate progressive narrowing throughout the patch,
with the largest changes at the distal end. Narrowing of the
lumen in the graft segment distal to the revision is also
observed. This is reflected by the change in the graft
minimum cross-sectional area in Table II, which represents
the distal end point of the patch.
The reproducibility study demonstrated a difference of
0.1 2.5 mm2 (0.3% 6.9%) in mean cross-sectional area
for the repeated scans of the patched sites. On the basis of
this variability measurement, seven revised graft segments
demonstrated a significant decrease in cross-sectional area
over time, ranging from 17% to 61%, averaged over the
length of the revision. Three grafts exhibited no statistically
significant change in size. Three of the four revisions at
valve sites changed by 17% or less, and one decreased in area
by 61%. Five of the six revisions at sites of diffuse intimal
hyperplasia demonstrated decreases in lumen area ranging
from 26% to 61%, and one case exhibited no significant
change in cross-sectional area. Overall, larger changes in
cross-sectional area were detected in the intimal hyperplasia
group (39% average change) compared with the valve
stenosis group (19% average change).
The final patch minimum and maximum values re-
ported in Table II indicate that one revision (case V2)
normalized to an essentially straight conduit (Fig 5); dila-
tations in the revised segments were present in all other
cases at the end of the study period. For comparison with
case V2, Fig 5 also shows serial 3D surface reconstructions
for case V4, which exhibited no measurable change in size
over the same length of time.
Surface reconstructions of cases H2 and H6 clearly
show the focal stenosis that developed during follow-up
(Fig 6). The final minima for these two cases in Table II
represent the cross-sectional area at the stenosis. The ste-
Fig 3. Percent change in mean cross-sectional area within revised segment plotted as function of time after revision.
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nosis in case H2 appeared at the junction of two adjacent
vein patches: a small proximal patch and a larger distal
patch. The stenosis in case H6 appeared at the distal end of
the patch, at the site of an anastomosis with an interposition
graft. The cross-sectional areas of these two stenoses are
plotted over time in Fig 7 with the mean cross-sectional
area of the full patch. In case H2, the patient had symptoms
at the time of the last study (32 weeks), and the patch was
further revised with a Dacron patch at 33 weeks. The
stenosis in case H6 progressed to a minimum cross-sec-
tional area at 42 weeks (94% area reduction). After this,
however, an increase in cross-sectional area was observed.
As shown in Figs 6 and 7, the narrowing, and regression in
case H6, were observed not just at the stenosis but
throughout the entire patch.
DISCUSSION
Since vein grafts are prone to develop stenosis that can
lead to graft occlusion, extensive work has been done to
detect these lesions at a time when they can be repaired
safely. Ultrasound duplex scanning is used at frequent
intervals to detect the high flow rate associated with devel-
opment of stenosis.7,17 This surveillance protocol permits
precise localization of the flow velocity increase at the site of
narrowing. However, there is no information on the re-
modeling process that takes place within the vein graft. An
unexpected finding in a previous long-term study of vein
grafts was that stenosis developed in 90%, yet only 27% of
the detected stenoses required repair.7 The remainder of
the stenoses did not progress or appeared to regress. While
the presumption is that a return of blood flow rate toward
normal indicates that true regression has occurred, there is
no imaging or histologic confirmation of this finding.
We present results from quantitative studies of revised
peripheral vein bypass grafts using 3D power Doppler
ultrasound scanning. 3D reconstructions have the potential
to provide additional detail and precision in the surveillance
of vein grafts, compared with 2D methods. Spatially regis-
tered cross-sectional area measurements in vein grafts can-
not be made reliably with standard real-time 2D ultra-
sound, because of variability in image plane location and
orientation. 3D representations preserve information about
the complete vessel geometry while enabling comparison of
spatially registered regions over time. Sections through the
3D surface at angles perpendicular to the vessel center axis
also assure proper determination of the cross-sectional area.
Review of routine clinical duplex graft surveillance ex-
aminations in our study patients indicates that consistent
flow velocity changes were not associated with the lumen
narrowing documented with the 3D ultrasound scans.
Changes in flow velocity can be particularly difficult to
define in anastomoses and patched graft segments because
of irregular geometry and complex blood flow pat-
terns.18,19 Spectral waveforms in dilated segments are char-
acterized by disturbed flow resulting from eddies, and it is
difficult to determine an appropriate Doppler measurement
angle relative to the vessel walls. These factors lead to
uncertainty in the identification of peak systolic flow veloc-
ity. Therefore 3D scanning provides anatomic information
that is not readily obtained with conventional duplex scan-
ning.
Close serial follow-up with 3D ultrasound scanning
provides not only a measure of lumen narrowing but also a
record of the rate and pattern of change over time. Several
studies demonstrated an increase in cross-sectional area
relative to the previous measurement at 8 to 12 weeks
during the study (Fig 3). Differences in narrowing rate
were then evident at 12 to 32 weeks. Within this period a
graft may be unchanged or enlarged and stable, narrowed
and stable, or progressively narrowing. In addition, one
case (case H6) demonstrated a change in the direction of
the remodeling late during follow-up. In this case the mean
cross-sectional area reached a minimum at 42 weeks (38%
change), after which the lumen enlarged. This change has
Table II. Mean cross-sectional area of patch for first and last studies of each revision and change in mean cross-sectional
area
Case
Initial mean
CSA (range*)
(mm2)
Final mean
CSA (range*)
(mm2)
Change in mean CSA†
(mm2) (%)
Valve stenosis
V1 37.0 (19.7, 51.1) 30.7 (17.2, 38.6) 6.3 17.0
V2 31.0 (17.4, 38.8) 12.1 (10.9, 13.6) 18.9 60.8
V3 25.7 (20.8, 31.4) 26.8 (16.3, 33.2) 1.1 4.6
V4 42.4 (18.4, 54.0) 40.8 (21.0, 50.2) 1.6 3.8
Diffuse intimal hyperplasia
H1 52.1 (24.0, 95.0) 24.4 (5.8, 60.8) 27.7 53.3
H2 35.4 (10.4, 65.7) 19.8 (0.9, 50.7) 15.6 44.1
H3 57.8 (52.0, 66.7) 22.5 (10.3, 38.8) 35.3 61.0
H4 49.9 (24.6, 118.9) 26.1 (14.2, 74.3) 23.8 47.7
H5 54.7 (15.0, 93.4) 52.5 (17.6, 104.0) 2.2 4.1
H6 66.0 (30.9, 79.7) 49.1 (4.6, 69.5) 16.9 25.6
CSA, Cross-sectional area.
*Range given as minimum and maximum values.
†Change in mean CSA given as final minus initial value.
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been confirmed in follow-up studies for an additional 2
years beyond the other cases. Case H6 has been followed
up to 134 weeks, and this patch has remained stable after
the initial regression, with mean area reduction ranging
from 21% to 28% over the past year.
3D analysis also enables comparison of changes in both
extended segments and at focal sites such as stenoses or
valves. This can help determine whether a stenosis forms as
a consequence of a general narrowing of a graft or is
associated with a localized response. For both stenoses
Fig 4. Cross-sectional area measurements for four surface reconstructions in case H1. Reconstructions are registered
within a common coordinate system to enable direct comparison of area changes over time. At the top, cross-sectional
area is plotted as a function of distance along the vessel. Cross-sectional area measurements are mapped to the surfaces
according to the color scale at the right. Arrows beneath the area plot indicate start and end points over which the mean
cross-sectional area is calculated for all cases. In this case the starting point for the comparison is determined by the
location of the initial point of the 9-week study, because it had the shortest extent proximal to the patch. Blood flow
is from left to right.
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followed up in the current study, overall narrowing of the
patch was also observed (Fig 6). In case H2, absolute
changes in the stenosis and mean cross-sectional area were
nearly equal (Fig 7, B). In Case H6, the rate and absolute
amount of narrowing at the point of the focal stenosis was
greater than that of the mean cross-sectional area. In case
H2, however, the graft required further revision when
symptoms returned at 32 weeks, whereas the stenosis in
case H6 regressed over time. The small size of the initial
graft in case H2 may have contributed to the return of
symptoms in this patient.
Power Doppler imaging was used because it averts the
problem of lateral dropout of the vessel walls that is com-
mon in B-mode ultrasound scanning. However, there are
some limitations associated with the power Doppler imag-
ing method. First, operator dependence can be a source of
variability in quantitative measures derived from power
Doppler images, in particular because the extent of the
depicted flow region varies with the gain setting. This effect
can be reduced by using the gray-scale display of the vessel
walls to provide feedback to the operator as to the correct
setting of the power Doppler gain. In addition, all patient
examinations were performed by one sonographer. Second,
note that the 3D surfaces generated by the automated color
segmentation algorithm provide measurements of the ves-
sel lumen only. Further studies to delineate the vessel wall
will be necessary to characterize the complete vessel remod-
eling process.
The magnetic tracking system used for 3D registration
permits arbitrary manipulation and positioning of the scan
head by the examiner for optimal imaging of the vessels of
interest. For typical vascular imaging applications the mag-
netic tracking system enables location of points in space
with precision of 0.5 to 1 mm.20,21 However, the magnetic
system is susceptible to interference from ferromagnetic
materials in the vicinity, and care must be taken to minimize
the presence of metals in the scanning area. Spatial regis-
tration of serial data sets can also contribute to measure-
ment variability. Initial registration of serial data sets is
achieved through use of fiducial points that are assumed to
remain stable over time with respect to the vein graft.
However, differences in placement of the transducer at the
external fiducial landmark or changes in leg configuration
from postoperative edema can lead to alignment errors.
Therefore a correlation based on the cross-sectional area
profile was used to optimize the final registration across
studies.
Fig 5. Serial 3D surface reconstructions of patched valve stenoses in case V2 (left) and case V4 (right). At 17 weeks
the patch site for case V2 has narrowed enough that the dilatation is no longer evident. Case V4 demonstrated no
significant change in size over the study period. Arrows beneath the top surface reconstructions indicate start and end
points of each patch. Blood flow is from left to right.
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The reproducibility results include the contributions of
image acquisition, 3D tracking, vessel segmentation, and
spatial registration to overall measurement variability. We
measured reproducibility of 6.9% in cross-sectional area
measurements. We can therefore consider cross-sectional
area changes greater than 14% to be significant with 95%
confidence. To appreciate the size changes detected, the
area measurements can be described in terms of vessel
diameter for the area-equivalent circular cross section. For
vessels with initial diameter of 5 to 10 mm, an area change
of 14% corresponds to diameter change of approximately
0.4 to 0.7 mm. Note that in a previous study we reported
reproducibility of 12.2% for cross-sectional area measure-
ments using a gray-scale image capture system and manual
outlining.13 This previous study also reported a 6% error
associated with manual outlining alone, based on repeated
tracings of data sets. The 5.3% improvement in reproduc-
ibility observed in the current study can be attributed to the
use of automated vessel segmentation with limited manual
editing. Of 3011 borders detected with automatic segmen-
tation for the repeatability study, 157 borders (5.2%) re-
quired manual editing.
While this study focused on dilated regions of the
grafts, precise measurement of cross-sectional area may also
reveal early size changes in straight segments of vein grafts.
Absolute flow velocity changes between visits are not reli-
able indicators of uniform diameter changes in straight
graft segments, and velocity ratios do not apply until nar-
rowing is such that increased flow velocity can be detected.
Early or progressive narrowing could indicate grafts that
require more frequent surveillance. Detection of changes in
graft geometry could also be useful in assessment of phar-
macologic treatment intended to reduce the incidence of
graft stenosis. Whether these changes in graft diameter can
serve as early indicators of later risk for stenosis is a subject
of continuing investigation with the 3D imaging method.
Studies in our laboratory are proceeding to track 3D geom-
etry changes in unrevised vein grafts.
CONCLUSION
Cross-sectional area measurements, spatially registered
over time, have been derived from 3D surface reconstruc-
tions of revised sites in lower extremity vein grafts. These
3D reconstructions provide documentation of anatomic
changes in areas of complex geometry where flow velocity
measurements are difficult to perform and interpret. Vari-
ous remodeling patterns were observed among a group of
patch angioplasty sites in the first year after revision, dem-
onstrating responses ranging from no appreciable change in
dilation to normalization into a straight conduit. Quanti-
tative monitoring of vein graft architecture may provide a
means to differentiate normal remodeling from pathologic
changes that lead to stenosis and threaten vein graft pa-
tency.
Fig 6. Surface reconstructions over time for two revisions in which focal stenoses (arrows) developed. In case H2,
further revision was required at 33 weeks after the initial vein patch. In case H6 the cross-sectional area regressed after
reaching a minimum at 42 weeks. Blood flow is from left to right.
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ANNOUNCING A NEW SECTION: VASCULAR IMAGES
The Vascular Images section presents interesting vascular images and associated short educational summaries in a
focused, case report format. One of the images will be chosen for the cover of each issue of the Journal. Submission
of color illustrations suitable for the Journal cover is encouraged. Appropriate images include radiographs, pathology,
anatomy, operative findings, and other relevant clinical pictures. The images should illustrate features of vascular
disease, including technical approaches. Illustrations and text must be confined to one printed page (no more than
350 words; perhaps less depending on the number and size of illustrations), and images for the cover should possess
both scientific and artistic merit. Descriptions of images must be included in the text, and only key references should
be provided (with a limit of two). Images must be of professional quality and should be provided electronically in
either TIFF or EPS format and uploaded (with the rest of the manuscript) via the Editorial Manager electronic
submission system at http://jvs.editorialmanager.com. Detailed artwork instructions and help with formatting,
sizing, scanning, and file naming can be found at http://www.elsevier.nl/homepage/sab/artwork. A high-
quality print or computer-generated image of each illustration must be submitted to the Journal office for accepted
submissions, even though the illustrations have been submitted previously via Editorial Manager. For more
information regarding hard copy requirements, please see “Guidelines to Complete Submission of an Accepted
Manuscript” at http://jvs.editorialmanager.com.
Contributions for the Vascular Images section are now invited.
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